Irini is responsible for leading the financial division of CRK. She is currently a post-doctoral researcher at the University of Oxford, investigating the immune response to radiation therapy in prostate cancer. Irini holds a BSc in Chemistry from the University of Athens, a MPharm in Pharmacy from King’s College London and a doctorate in Oncology from the University of Oxford, where she investigated targeted therapies for breast cancer.